
Global Short Sellers Circle Live Nation, Marriott, Kering, and ANTA Sports as Recession Fears Rise
NEW YORK & LONDON--(BUSINESS WIRE)--The increased risks of a potential recession have continued to gain momentum over the last several months, and short sellers have taken note, according to the latest Hazeltree May 2025 Shortside Crowdedness Report. Major consumer brands, including half of the top-10 most crowded shorts in the Americas, were identified by , a leader in active treasury and intelligent operations technology for the alternative asset industry, alongside notable companies such as Live Nation Entertainment, Inc., Chevron Corporation, Marriott International, Inc., Charter Communications, and Dell Technologies Inc. Overseas, luxury goods fashion conglomerates Kering S.A. and LVMH were among the most crowded shorts in EMEA, with a score of 99, followed by consumer lifestyle sporting goods and leisure lifestyle brands ANTA Sports Products Limited and Oriental Land Co., Ltd., which ranked among the top crowded shorts in APAC.
The report is a monthly listing of the top 10 most crowded shorted securities in the Americas, EMEA, and APAC regions, categorized by large-, mid-, and small-cap ranges. Hazeltree compiles data from its proprietary securities finance platform data, which tracks approximately 15,000 global equities across the Americas, EMEA, and APAC. The data, available to select clients, is aggregated and anonymized from the contributing Hazeltree community, which comprises approximately 700 asset management funds. The firm assigns securities a Hazeltree Crowdedness Score, a key metric that grades securities on a scale of 1 to 99, with 99 representing the highest concentration of shorting activity. This scoring highlights securities most targeted by investors and reflects key supply-demand dynamics.
'We witnessed an extension of consumer spending taking root across the globe as major lifestyle brands shot to the top of Hazeltree's most crowded shorts across companies focused on entertainment, energy, fashion, travel, electronics, and more,' said Tim Smith, Managing Director of Data Insights at Hazeltree. 'In the Americas, we also noticed large-cap stocks turning back toward tech, with five out of the most crowded shorts from four in April. Mid-cap company MARA Holdings, Inc. - the digital asset crypto mining company - also is a noteworthy standout and had an unusually high institutional supply utilization at 72.48% with the increasing investing fervor around Bitcoin.'
Highlights from the May 2025 report include:
Americas
In the large-cap category, Live Nation Entertainment, Inc. and Chevron Corporation were the most crowded securities with a score of 99. Super Micro Computer, Inc. became the second most crowded security with a score of 97 and held the highest institutional supply utilization figure (48.24%) for the sixth straight month.
In the mid-cap category, Albemarle Corporation is the most crowded security for the second time in 2025 with a Hazeltree Crowdedness Score of 99, while MARA Holdings, Inc. held the highest institutional supply utilization figure (72.48%).
In the small-cap category, Kohl's Corporation was the most crowded security with a score of 99. PureCycle Technologies, Inc. had the highest institutional supply utilization (83.49%).
EMEA
In the large-cap category, Kering S.A. rejoined LVMH as the most crowded securities with a score of 99 and BE Semiconductor Industries N.V. had the highest institutional supply utilization (32.68%).
In the mid-cap category, Davide Campari-Milano N.V. was the most crowded security (99) and had the highest institutional supply utilization (55.94%).
In the small-cap category, WH Smith PLC, SSP Group plc, CVS Group plc, Senior PLC, and Basic-Fit N.V. were the most crowded securities, achieving a score of 99. Basic-Fit N.V. also topped institutional supply utilization (88.70%) for the second straight month.
APAC
In the large-cap category, Fujikura Ltd. ascended to the top with a score of 99. Quanta Computer Inc. had the highest institutional supply utilization (22.24%).
In the mid-cap category, Mercari, Inc. reappeared for the second month, joined by Ibiden Co., Ltd. and WuXi AppTec Co., Ltd., as the most crowded securities with a score of 99. WuXi AppTec also held the highest institutional supply utilization for the last three months (42.66%).
In the small-cap category, Tokai Carbon Co., Ltd. and Ganfeng Lithium Group Co Ltd were the most crowded securities (99). Ganfeng had the highest institutional supply utilization (52.07%).
To view Hazeltree's May 2025 Shortside Crowdedness Report and past reports, click here.
Note to editors: If you are a member of the media/press and would like to be included on the distribution list for this report, please contact btanner@hazeltree.com.
Hazeltree Shortside Crowdedness Report Methodology
The Shortside Crowdedness Report tracks shorting activity in three different metrics:
Hazeltree Crowdedness Score: This score represents securities that are being shorted by the highest percentage of funds in Hazeltree's community in a pre-defined category. The securities are graded on a scale of 1-99, with 99 representing the security that the highest percentage of funds are shorting.
Institutional Supply Utilization: This figure represents the percentage of the institutional investors' supply of a particular security that is being lent out. The institutional supply utilization rate is an indicator of how 'hot' a security is in terms of the supply-demand dynamic. It is possible to see 100% utilization of a security's availability, making it difficult to establish new short positions.
Hazeltree Community Borrow Fee: This figure is the average weighted fee for what funds in the Hazeltree community are paying to borrow a security. The fee is represented as the annualized cost calculated as a percentage of the price of the security.
About Hazeltree
Hazeltree is a leader in active treasury and intelligent operations technology. Purpose-built for the alternative asset management ecosystem, Hazeltree's modular platform aggregates internal and external data, providing a comprehensive view of operations and counterparty relationships while proactively highlighting opportunities to extract more value from every transaction. Hazeltree is headquartered in New York with offices in London, Bournemouth, and Hong Kong. For more information, please visit www.hazeltree.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Centuri Holdings (CTRI) Surged This Week. Here is Why.
The share price of Centuri Holdings, Inc. (NYSE:CTRI) surged by 9.74% between May 29 and June 5, 2025, putting it among the Energy Stocks that Gained the Most This Week. Let's shed some light on the development. A close-up of an electrical power line with a bright blue sky in the background, highlighting the company's selection of electricity and natural gas services. Centuri Holdings, Inc. (NYSE:CTRI) is a strategic utility infrastructure services company that partners with regulated utilities to build and maintain the energy network that powers millions of homes and businesses across the United States and Canada. Centuri Holdings, Inc. (NYSE:CTRI) continues to surge after the company announced $350 million in new customer awards in late May, reflecting strong demand for the company's infrastructure solutions across North America. The awards span the United States and include work supporting electric and gas infrastructure modernization, water relocation, utility distribution, and renewables. This comes after Centuri Holdings had already announced nearly $490 million in multi-year customer awards earlier this year. The share price of Centuri Holdings, Inc. (NYSE:CTRI) has gained almost 23% over the last month. While we acknowledge the potential of CTRI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Cheap Energy Stocks to Buy Now and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Array Technologies (ARRY) Gained Over 11% This Week. Here is Why.
The share price of Array Technologies, Inc. (NASDAQ:ARRY) surged by 11.78% between May 29 and June 5, 2025, putting it among the Energy Stocks that Gained the Most This Week. Let's shed some light on the development. An aerial view of a solar panel farm, its panel incremented tracking the sun's path. Array Technologies, Inc. (NASDAQ:ARRY) is a leading global provider of solar tracking technology to utility-scale and distributed generation customers, who construct, develop, and operate solar PV sites. Array Technologies, Inc. (NASDAQ:ARRY) fell by over 20% last month after investors reacted negatively to President Trump's sweeping tax and spending bill advancing through the House of Representatives, which may result in the termination of numerous subsidies that have supported the renewable energy sector. The bill is expected to have devastating consequences for the booming solar industry, which relies heavily on such credits. So ARRY's recent rebound could be due to investors flocking in to purchase the stock at a lower, more attractive price. Moreover, it must be mentioned that Array Technologies, Inc. (NASDAQ:ARRY) posted strong results in its Q1 2025 last month, beating forecasts in both revenue and earnings. Moreover, the company achieved the second-largest quarter of volume shipped since 2023 and maintained its guidance for the full year 2025. While we acknowledge the potential of ARRY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Cheap Energy Stocks to Buy Now and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory
We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. (REGN) on Notes From The Beauty Contest's Substack. In this article, we will summarize the bulls' thesis on REGN. Regeneron Pharmaceuticals, Inc. (REGN)'s share was trading at $605.39 as of 29th May. REGN's trailing and forward P/E were 15.39 and 17.39 respectively according to Yahoo Finance. A scientist in a lab conducting research on cell-based therapeutics and biotechnology. Regeneron's latest earnings report was notably weak, with a 3.7% revenue decline and a 14% EPS drop, surprising given the company's history of exceeding market expectations. The primary driver was a steep 26% year-over-year decline in the U.S. Eylea franchise, particularly a 39% drop in 2mg Eylea sales. This was partly due to a co-pay assistance funding gap, which forced many Medicare patients to switch to cheaper alternatives like compounded Avastin, impacting both Regeneron and rival Roche's Vabysmo. Regeneron, having contributed over $400 million last year to charitable foundations supporting co-pay assistance, is now seeking to share this burden, proposing a matching donation program to encourage broader industry support. Another setback was the FDA's Complete Response Letter delaying approval of the Eylea-HD pre-filled syringe, a key product needed to compete with Vabysmo. The delay stemmed from third-party component issues rather than drug efficacy, and management believes resolution could be near. Margins also contracted, with gross margin falling from 89% to 85% due to unspecified inventory write-offs, possibly related to older Eylea 2mg or even leftover REGEN-COV stock. However, the margin pressure appears more tied to one-offs and increased R&D spending than structural issues. On a more positive note, Regeneron's pipeline is broadening meaningfully. Itepekimab, an IL-33 antibody, shows promise as a major respiratory asset with pivotal COPD data upcoming and expanded trials underway. The growing RNAi pipeline, now at nine siRNAs through its Alnylam collaboration, signals Regeneron's potential evolution beyond antibodies into a broader genetic medicine powerhouse. Regeneron Pharmaceuticals, Inc. (REGN) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 66 hedge fund portfolios held REGN at the end of the first quarter which was 68 in the previous quarter. While we acknowledge the potential of LYFT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey. Sign in to access your portfolio